BASEL, Switzerland, Sept. 16, 2025 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) shared real-world evidence from the rollout of Accu-Chek SmartGuide continuous glucose monitoring (CGM) solution ...

Roche Holding RHHBY recently announced that it has received the CE Mark for its Accu-Chek SmartGuide continuous glucose monitoring (CGM) solution. With the approval, CGM solution can now be made ...

Roche has received the CE mark of approval for the integration of the mySugr app with its Accu-Chek SmartGuide and is set to launch it later this year.

Roche, a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives, announced the launch of the Accu-Chek Guide, the next-generation blood glucose ...

Health Canada has issued a recall for some Accu-Chek Guide devices due to inaccurate blood glucose readings. Certain units of the medical measurement device incorrectly display blood glucose levels, ...

Roche HoldingsRHHBY announced the launch of a next-generation blood glucose (BG) monitoring system, Accu-Chek Guide. The new monitoring system will enable BG monitoring much simpler thanks to its ...

Roche announced its partnership with the digital therapeutic company Wellthy Therapeutics to offer users of the Accu-Chek Active system, a clinically validated artificial intelligence-based digital ...

The integration of Accu-Chek SmartGuide's AI-enabled predictive CGM with the popular mySugr app delivers a simple, intuitive solution for people to manage their diabetes with greater ease.Accu-Chek ...